SCHEMBL532832

SCHEMBL532832

COc1ccc(S(=O)(=O)Nc2c(C)cc(C)c(N3CCCC3)c2C)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.60
ALDH1A1 P00352 5/20 0.54
BRPF1 P55201 1/20 0.53
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
CYP2C9 P11712 2/20 0.49
MAPT P10636 1/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
TP53 P04637 2/20 0.48
EDNRA P25101 1/20 0.47
ALOX15 P16050 1/20 0.47
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532953 0.86 FFAR4 (0.59) FFAR4ALDH1A1SMN1; SMN2MAPTKEAP1
SCHEMBL534062 0.83 ERAP1 (0.52) ALDH1A1SMN1; SMN2LMNATSHRTP53
SCHEMBL533017 0.83 FFAR4 (0.55) FFAR4ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL532935 0.82 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNAMAPTTP53
SCHEMBL532951 0.81 EDNRB (0.45) FFAR4ALDH1A1BRPF1SMN1; SMN2LMNA
SCHEMBL14288678 0.81 ALDH1A1 (0.52) ALDH1A1BRPF1HTTSMN1; SMN2LMNA
SCHEMBL534065 0.81 PKM (0.53) SMN1; SMN2EDNRAALOX15
SCHEMBL533055 0.81 ALDH1A1 (0.45) FFAR4ALDH1A1SMN1; SMN2CYP2C9MAPT
SCHEMBL533666 0.81 FFAR4 (0.56) FFAR4ALDH1A1HTTLMNAMAPT
SCHEMBL532880 0.81 FFAR4 (0.56) FFAR4ALDH1A1HTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed